The Kings beat Lakers
Harrison Barnes tied a season record with seven three-pointers on his way to a team-record 23 points, Domantas Sabonis had a triple-double, and the Sacramento Kings survived a late charge…
Italy’s regulator has fined TikTok $11 million
Italian antitrust regulator AGCM said Thursday it has fined three TikTok units a total of 10 million euros ($10.94 million) for inadequately vetting content on its platform that could be…
Taylor Swift reveals ‘You Are in Love’ as an acoustic track on Disney+ version of ‘Eras Tour’
Taylor Swift has revealed that "You Are in Love" is another of the bonus acoustic songs on the upcoming Disney+ version of her concert film "Eras Tour". Other acoustic songs…
Dua Lipa, Coldplay and SZA to headline Glastonbury festival
Dua Lipa, SZA and Coldplay will headline Glastonbury Festival for the first time. British-Albanian Dua Lipa will make her Pyramid Stage debut shortly after the release of her third album…
Infineon has filed a patent lawsuit against Chinese company Innoscience
German chip maker Infineon said on Thursday it has filed a patent lawsuit against China's Innoscience in a US court over its semiconductor technology. Infineon said it is seeking an…
Kung Fu Panda 4 will still lead at the box office
Kung Fu Panda 4, last weekend's winner, is expected to dominate again with between $28 million and $30 million in its second opening. To date, the animated sequel has grossed…
Oracle adds generative AI features to software
Oracle on Thursday said it is adding generative artificial intelligence features to its line of enterprise software, intensifying competition with Microsoft and other technology firms to sell the technology to…
Merck is testing a single dose of Gardasil 9 HPV vaccine
Merck & Co said on Wednesday it plans to conduct a clinical trial of its human papillomavirus (HPV) vaccine Gardasil 9 to evaluate the efficacy and safety of a single-dose…
Shell weakens target to reduce carbon emissions by 2030
Shell weakened its 2030 carbon reduction target and abandoned its 2035 target, citing expectations of lower electricity sales and high gas demand in the energy transition, even as it reaffirmed…
AstraZeneca to buy Amolit Pharma for $1.05bn to boost rare disease portfolio
Drug maker AstraZeneca said on Thursday it will acquire rare endocrine disease company Amolyt Pharma for $1.05 billion in cash in a bid to boost its rare disease portfolio.
- Go to the previous page
- 1
- …
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- …
- 228
- Go to the next page
